RGIN
Price:
$0.0001
Market Cap:
$15.35K
Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Industry
Biotechnology
IPO Date
2009-11-16
Stock Exchange
OTC
Ticker
RGIN
According to Regenicin, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.00. This represents a change of -99.17% compared to the average of 0.33 of the last 4 quarters.
The mean historical Current Ratio of Regenicin, Inc. over the last ten years is 0.16. The current 0.00 Current Ratio has changed 77.53% with respect to the historical average. Over the past ten years (40 quarters), RGIN's Current Ratio was at its highest in in the March 2015 quarter at 1.49. The Current Ratio was at its lowest in in the June 2022 quarter at 0.00.
Average
0.16
Median
0.02
Minimum
0.00
Maximum
0.66
Discovering the peaks and valleys of Regenicin, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.69%
Maximum Annual Current Ratio = 0.66
Minimum Annual Increase = -92.29%
Minimum Annual Current Ratio = 0.00
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 0.00 | 197.23% |
| 2021 | 0.00 | -3.75% |
| 2020 | 0.00 | -32.23% |
| 2019 | 0.00 | -92.29% |
| 2018 | 0.02 | -46.81% |
| 2017 | 0.03 | -78.31% |
| 2016 | 0.16 | -75.69% |
| 2015 | 0.66 | 0.70% |
| 2014 | 0.65 | 2.69% |
| 2013 | 0.02 | -6.06% |
The current Current Ratio of Regenicin, Inc. (RGIN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.00
5-year avg
0.00
10-year avg
0.16
Regenicin, Inc.’s Current Ratio is less than VioQuest Pharmaceuticals, Inc. (0.22), less than Q BioMed Inc. (0.01), less than Scopus BioPharma Inc. (0.05), less than Poniard Pharmaceuticals, Inc. (3.23), less than Aeolus Pharmaceuticals, Inc. (4.25), less than RenovaCare, Inc. (2.59), less than Strategic Partners A/S (13.90), less than NanoLogix, Inc. (1.08), less than Vaxxinity, Inc. (1.89), less than NovAccess Global Inc. (0.01),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.22 | $14.72K | |
| 0.01 | $14.51K | |
| 0.05 | $16.83K | |
| 3.23 | $150.00 | |
| 4.25 | $15.21K | |
| 2.59 | $8.73K | |
| 13.90 | $3.72M | |
| 1.08 | $11.96K | |
| 1.89 | $12.68K | |
| 0.01 | $6.17K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regenicin, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regenicin, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Regenicin, Inc.'s Current Ratio?
How is the Current Ratio calculated for Regenicin, Inc. (RGIN)?
What is the highest Current Ratio for Regenicin, Inc. (RGIN)?
What is the 3-year average Current Ratio for Regenicin, Inc. (RGIN)?
What is the 5-year average Current Ratio for Regenicin, Inc. (RGIN)?
How does the current Current Ratio for Regenicin, Inc. (RGIN) compare to its historical average?